For instance, primary care-based buprenorphine treatment has previously been shown to be effective in treatment patients with OUD with similar outcomes in terms of treatment engagement to subspecialty care.4 All health care providers can help reduce the burden of substance use disorders. Universal screening, empathetic communication, and medical treatment can save lives and transform the trajectory of patients struggling with substance use. While there are a variety of evidence-based and promising practices related to SUD and overdose prevention, there remain significant gaps in researchers’ and practitioners’ understanding. Public funds addressing overdose trends should ensure individual-, interpersonal-, and macro-level investments across the primary, secondary, and tertiary prevention spectrum and support continued research on intended and unintended health outcomes of all funded interventions.
Supporting Patients with Substance Use Disorders
Promoting mental health and preventing mental and/or substance use disorders are fundamental to SAMHSA’s (Substance Abuse and Mental Health Services Administration) mission to reduce the impact of behavioral health conditions in America’s communities. In addition to life skills training programs, there are also a number of other universal SUD prevention interventions in adolescents and young adults, which focus on providing feedback about substance use, risk behaviors, health, and well-being. While initial studies suggest that higher doses of specific stimulants may be beneficial for a subset of individuals with comorbid ADHD and stimulant use disorder, it is crucial to emphasize that more research is needed to establish the safety and efficacy of such treatments in this complex population 74. In essence, addressing the comorbidity of stimulant use disorders and ADHD calls for a nuanced approach that carefully considers the intricate interplay of various factors and acknowledges the existing gaps in evidence 75.
- Thus, each level is not only dependent on but also instrumental in shaping the dynamics of the others, thereby creating a complex web of interconnected influences.
- Despite these challenges, the serial care approach still offers valuable insights that can significantly inform our understanding and treatment of concurrent disorders.
- In the realm of comorbid SUDs and psychiatric conditions, harm reduction strategies emerge as a pragmatic and compassionate approach to care.
- A socioecological framework for SUD prevention recognizes the complex interactions between people and their environments at the individual, interpersonal, and macro levels (Agency for Toxic Substances and Disease Registry, 2015; Bronfenbrenner, 1979).
However, these interpersonal factors do not exist in isolation; they are influenced and shaped by macro-level factors, such as drug control policies, fragmented and unaccountable treatment delivery systems, concentrated poverty, and stigmatizing cultural narratives about people with OUD. Thus, each level is not only dependent on but also instrumental in shaping the dynamics of the others, thereby creating a complex web of interconnected influences. A socioecological framework for SUD prevention recognizes the complex interactions between people and their environments at the individual, interpersonal, and macro levels (Agency for Toxic Substances and Disease Registry, 2015; Bronfenbrenner, 1979). Social epidemiologic research supports the assertion that the context in which individuals make health-related choices serves as a barrier to or facilitates health (Galea, Nandi, and Vlahov, 2004; DuBois, 2003).
Tertiary Prevention of OUD Using a Socioecological Model
This risk or protection is likely mediated by deviations in the normative trajectories of brain structure, function, and neuropsychological functioning, which are also transdiagnostic in nature. This, in turn, leads to differences in temperament, which can increase the risk of developing psychopathology. This framework can also be used to study the effect of preventive interventions that modify these risk and protective factors.
These disorders involve patterns of behaviors that might include using more of the substance than planned, finding it difficult to stop, or continuing to use despite knowing it’s causing harm. Use these free digital, outreach materials in your community and on social media to spread the word about mental health. Use these free education and outreach materials in your community and on social media to spread the word about mental health and related topics.
Parenting or family interventions
Many of the interventions at this stage are typically categorized as harm reduction; however, it is worth noting that harm reduction includes a spectrum of interventions, including strategies across the primary and secondary levels of prevention. The coexistence of SUDs and psychiatric conditions challenges clinicians, researchers, and policymakers to adopt multifaceted approaches that acknowledge the complexity of these dual diagnoses. This review has shed light on the intricate interplay between psychological, biological, and social factors that define comorbidity. It underscores the importance of individualized care, embracing integrated treatment models, and recognizing the limitations of pharmacological interventions in isolation. Furthermore, the “Trojan Horse” concept has highlighted the need for nuanced approaches that consider the multifaceted nature of concurrent disorders. It is important to note that while harm reduction has made substantial strides in addressing the challenges faced by individuals with SUDs, its impact on those with comorbid conditions remains less well-defined.
Integrated operational framework for mental health, brain health and substance use
Prevention research over the years has emphasized that working in an isolated fashion with individuals, families, or schools is insufficient to make meaningful reductions in adverse mental health outcomes, such as substance use at the population level. This has led to the adoption of community-based prevention models in many parts of the world, which focus not only on reducing problem behaviors but also enhance a sense of well-being and ownership among communities. There are a number of interventions that have been tested for the prevention of substance use among adolescents. Psychosocial interventions incorporate both general aspects of well-being, such as building life skills and personality development, and more substance-specific aspects, such as substance use education and resistance skills. It is important to recognize that a number of the factors outlined confer risk or protection for a range of mental health conditions, including psychosis, depression, anxiety, and SUD. Furthermore, they seem to operate from the antenatal period through infancy, childhood, and adolescence, long before the symptoms of mental illness become apparent.
- This review has shed light on the intricate interplay between psychological, biological, and social factors that define comorbidity.
- Comorbidity in these domains carries profound implications for clinical practice, research, and policymaking, emphasizing the need for a holistic understanding of the intricate dynamics that arise when these conditions coexist.
- Many of the interventions at this stage are typically categorized as harm reduction; however, it is worth noting that harm reduction includes a spectrum of interventions, including strategies across the primary and secondary levels of prevention.
- Experts attest that an optimal mix of prevention interventions is required to address substance use issues in communities because they are among the most difficult social problems to prevent or reduce.
They believe that by focusing on and addressing their underlying psychiatric comorbidities, like depression or anxiety, they are essentially introducing a ‘hidden’ solution that will surreptitiously infiltrate and resolve their substance use issues. First, it fails to acknowledge how underlying factors can contribute to the development of both conditions, assuming a simplistic cause-and-effect relationship (e.g., suggesting that an individual’s alcohol use ‘caused’ their depression or anxiety). Second, it does not consider that during certain prevention of substance use and mental disorders forms of substance detoxification, the withdrawal phase can exacerbate concurrent psychiatric disorder symptoms (e.g., individuals may experience heightened anxiety or depression during acute alcohol withdrawal, potentially leading to a resumption of alcohol use). This underscores the idea that substance use often serves a role as a form of self-medication, with individuals using substances for specific reasons and rationales.
PREVENTIVE INTERVENTIONS FOR SUD
Additionally, given their ability to leverage existing resources in the community and convene diverse organizations, community coalitions connote a type of collaboration that is considered to be sustainable over time. You may also develop tolerance—meaning that over time you might need higher doses to relieve your pain, putting you at higher risk for a potentially fatal overdose. You can also develop physical dependence—meaning you have withdrawal symptoms when the medication is stopped. Opioid Use Disorder (OUD), a substance use disorder, sometimes referred to as “opioid abuse or dependence” or “opioid addiction” is a problematic pattern of opioid use that causes significant impairment or distress. OUD is a treatable, chronic disease that can affect anyone – regardless of race, sex, income level, or social class.
Connect with NIMH
The support of prevention programs through the ACA is a critical recognition of the need for federal support for prevention. Ultimately, the federal government must move beyond separate grant funding for prevention and build prevention into mainstream health care to ensure adequate translation into practice. Yet, despite this knowledge, the American healthcare system continues to ignore problems until they reach crisis levels.
Research has demonstrated that MOUD is especially effective in helping people recover from their OUD;456counseling and psychosocial support may also provide additional benefit for some patients. Moreover, the co-occurrence of ADHD in individuals with stimulant use disorders introduces additional layers of complexity in diagnosis and treatment. This is because the symptoms of stimulant intoxication and withdrawal can closely mimic those of ADHD 70.
This reductionist view diverted attention from the myriad of contextual factors related to the onset and progression of SUD (Herzberg et al., 2016; Wailoo, 2014). Consequently, some individuals resorted to seeking illicit alternatives for pain relief, paradoxically exacerbating the very issue that the guideline sought to address (Coffin et al., 2020). Cultural and linguistic competence includes, but is not limited to, the ability of an individual or organization to interact effectively with people of different cultures. To produce positive change, prevention practitioners must understand the cultural and linguistic context of the community, and they must have the willingness and skills to work within this context.
This integrated operational framework provides an overview of the connections between mental health, neurological and substance use (MNS) conditions, and… You can discuss your specific circumstances and situation to find treatments that are effective for your body. Share your concerns about the benefits and risks of prescription opioids and other pain treatment strategies.
These experiences then physically manifest via stress response mechanisms (Hatzenbuehler et al., 2015; Geller et al., 2014). Additionally, macro-level factors shape the interpersonal structures in communities, influencing individuals’ access to resources and opportunities, and their health-related behaviors and beliefs. Importantly, the interplay among levels is interdependent and multidirectional, with influences at one level often facilitated or inhibited by elements at another level.
As a result, clinicians often approach the prescription of psychostimulants with caution, concerned about the potential for worsening substance use outcomes and the risk of misuse 69,71. In such cases, non-stimulant medications like atomoxetine are frequently preferred despite the potential advantages offered by long-acting prescription stimulants 72,73. It is important to recognize that untreated depression and anxiety are significant risk factors for alcohol use disorder. Moreover, it is essential to differentiate between the common co-occurrence of these conditions and the notion that SSRIs directly ‘cause’ alcohol use. In fact, some research suggests that combining SSRIs with AUD treatment can yield significant benefits, emphasizing the critical importance of addressing both conditions concurrently 60,61,62. Moreover, Cochrane reviews have highlighted the potential utility of SSRIs in treating MDD, anxiety disorders, AUD, or combinations of these conditions in individuals with co-occurring AUD, with minimal risk of adverse effects 63,64.